Mexico GM: Growth, Access & Impact Lead

Bristol-Myers Squibb Co; Ciudad de México; On-site; MXN 3,000,000 - 6,000,000; Full time

Job summary

Bristol Myers Squibb in Mexico City seeks a General Manager to lead the Mexico affiliate with full P&L accountability and end-to-end responsibility for commercial strategy, market access, and organizational leadership.

This is the most senior leadership role in the country, reporting to LATAM VP, shaping strategy across public and private segments while driving patient access and sustainable growth in a complex market.

Qualifications

• Bachelor's degree required; MBA or advanced degree strongly preferred.
• 10+ years of experience in the pharmaceutical/healthcare industry, with significant experience in Mexico or a similarly complex emerging market.
• Proven track record in commercial leadership, including full P&L management.
• Demonstrated success launching and commercializing pharmaceutical products across public and private market segments.

Responsibilities

• Own full P&L and OPEX accountability for Mexico, delivering sustainable revenue growth and market share expansion.
• Define and execute strategic plans for Mexico, aligned with LATAM and global priorities.
• Lead an integrated commercialization strategy to expand patient access and maximize impact across public and private segments.
• Provide end-to-end leadership across all commercial functions (sales, marketing, market access).
• Serve as the primary external representative of BMS in Mexico, engaging government, payers, healthcare institutions, and industry groups.

Skills

Fluency in Spanish

Fluency in English

Education

Bachelor's degree

MBA or Advanced degree

Job description

Bristol Myers Squibb in Mexico City seeks a General Manager to lead the Mexico affiliate with full P&L accountability and end-to-end responsibility for commercial strategy, market access, and organizational leadership.

This is the most senior leadership role in the country, reporting to LATAM VP, shaping strategy across public and private segments while driving patient access and sustainable growth in a complex market.